These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35064362)

  • 21. Non-coding Transcripts from Enhancers: New Insights into Enhancer Activity and Gene Expression Regulation.
    Chen H; Du G; Song X; Li L
    Genomics Proteomics Bioinformatics; 2017 Jun; 15(3):201-207. PubMed ID: 28599852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide analysis of enhancer RNA in gene regulation across 12 mouse tissues.
    Cheng JH; Pan DZ; Tsai ZT; Tsai HK
    Sci Rep; 2015 Jul; 5():12648. PubMed ID: 26219400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity among enhancer RNAs: origins, consequences and perspectives.
    Syed KM; Hon CC
    Essays Biochem; 2021 Oct; 65(4):709-721. PubMed ID: 34414426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.
    Jiao W; Chen Y; Song H; Li D; Mei H; Yang F; Fang E; Wang X; Huang K; Zheng L; Tong Q
    Oncogene; 2018 May; 37(20):2728-2745. PubMed ID: 29511351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cis-acting lnc-eRNA SEELA directly binds histone H4 to promote histone recognition and leukemia progression.
    Fang K; Huang W; Sun YM; Chen TQ; Zeng ZC; Yang QQ; Pan Q; Han C; Sun LY; Luo XQ; Wang WT; Chen YQ
    Genome Biol; 2020 Nov; 21(1):269. PubMed ID: 33143730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancer-derived RNA: A Primer.
    Liu F
    Genomics Proteomics Bioinformatics; 2017 Jun; 15(3):196-200. PubMed ID: 28533025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The emerging role of super enhancer-derived noncoding RNAs in human cancer.
    Wang Y; Nie H; He X; Liao Z; Zhou Y; Zhou J; Ou C
    Theranostics; 2020; 10(24):11049-11062. PubMed ID: 33042269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation.
    Li W; Notani D; Ma Q; Tanasa B; Nunez E; Chen AY; Merkurjev D; Zhang J; Ohgi K; Song X; Oh S; Kim HS; Glass CK; Rosenfeld MG
    Nature; 2013 Jun; 498(7455):516-20. PubMed ID: 23728302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancer RNAs: transcriptional regulators and workmates of NamiRNAs in myogenesis.
    Odame E; Chen Y; Zheng S; Dai D; Kyei B; Zhan S; Cao J; Guo J; Zhong T; Wang L; Li L; Zhang H
    Cell Mol Biol Lett; 2021 Feb; 26(1):4. PubMed ID: 33568070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades.
    Napoli S; Munz N; Guidetti F; Bertoni F
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers.
    Honda S; Loher P; Shigematsu M; Palazzo JP; Suzuki R; Imoto I; Rigoutsos I; Kirino Y
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3816-25. PubMed ID: 26124144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.
    Toropainen S; Niskanen EA; Malinen M; Sutinen P; Kaikkonen MU; Palvimo JJ
    Sci Rep; 2016 Sep; 6():33510. PubMed ID: 27641228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential.
    Lee JH; Xiong F; Li W
    RNA Biol; 2020 Nov; 17(11):1550-1559. PubMed ID: 31916476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional annotation of structural ncRNAs within enhancer RNAs in the human genome: implications for human disease.
    Ren C; Liu F; Ouyang Z; An G; Zhao C; Shuai J; Cai S; Bo X; Shu W
    Sci Rep; 2017 Nov; 7(1):15518. PubMed ID: 29138457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging Role of Enhancer RNAs as Potential Diagnostic and Prognostic Biomarkers in Cancer.
    Panahi-Moghadam S; Hassani S; Farivar S; Vakhshiteh F
    Noncoding RNA; 2022 Oct; 8(5):. PubMed ID: 36287118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FAL1: A critical oncogenic long non-coding RNA in human cancers.
    Lv X; Li Y; Li Y; Li H; Zhou L; Wang B; Zhi Z; Tang W
    Life Sci; 2019 Nov; 236():116918. PubMed ID: 31610208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective study revealing the role of an immune-related eRNA, WAKMAR2, in breast cancer.
    Wang L; Liu J; Tai J; Zhou N; Huang T; Xue Y; Quan Z
    Sci Rep; 2021 Jul; 11(1):15328. PubMed ID: 34321580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancer RNAs: a class of long noncoding RNAs synthesized at enhancers.
    Kim TK; Hemberg M; Gray JM
    Cold Spring Harb Perspect Biol; 2015 Jan; 7(1):a018622. PubMed ID: 25561718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancer RNAs and regulated transcriptional programs.
    Lam MT; Li W; Rosenfeld MG; Glass CK
    Trends Biochem Sci; 2014 Apr; 39(4):170-82. PubMed ID: 24674738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. eNEMAL, an enhancer RNA transcribed from a distal MALAT1 enhancer, promotes NEAT1 long isoform expression.
    Stone JK; Vukadin L; Ahn EE
    PLoS One; 2021; 16(5):e0251515. PubMed ID: 34019552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.